Ortivus

Board/Management Information • Apr 5, 2024

The Nomination Committee proposes a new Chairman of the Board for Ortivus AB

The Nomination Committee proposes Anna-Carin Strandberg for election as the new Chairman of the Board of Ortivus AB at the Annual General Meeting on May 8, 2024. This decision follows the announcement by the current Chairman of the Board, Anders Paulsson, to the Nomination Committee that he will not be available for re-election.

Anders Paulsson, Ortivus' Chairman of the Board since 2019, has announced that due to personal reasons, he will not be available for re-election at the company's Annual General Meeting on May 8, 2024. Consequently, the company's Nomination Committee has decided to nominate the current board member, Anna-Carin Strandberg, as the new Chairman of the Board for Ortivus.

"Anna-Carin Strandberg was elected to the board during the Annual General Meeting in 2023, and our assessment is that she possesses the competence and experience required to assume the position of Chairman of the Board after Anders Paulsson. We extend our gratitude to Anders for his significant contributions during his tenure at Ortivus," stated Konstantin Papaxanthis, Chairman of the Nomination Committee.

Contacts

For further information, please contact

Gustaf Nordenhök, CEO

Telefon +46 8 446 45 00

About Ortivus

Ortivus develops and commercialises MobiMed, e-health and medical technology solutions for a safer and more efficient healthcare. The company was founded in 1985 and is today a leading provider of mobile digital solutions for prehospital care, worldwide. Ortivus' innovations are based on in-depth expertise in cardiology as well as decades of development together with users and customers. The company's headquarters are located in Danderyd, Stockholm. The company has, since 1998, a wholly owned subsidiary based in the United Kingdom and since 2022, a wholly owned subsidiary based in Denmark.

MobiMed is a modular platform that connects and enable real-time information sharing throughout the prehospital care chain. It is currently used by over 12,000 paramedics in over 2,700 emergency vehicles. The platform, MobiMed, consists of several product modules that are completely integrated but can also be used stand-alone. MobiMed comprises four main solutions: MobiMed Monitor, that measures, monitors and shares patients' vital parameters and ECG in realtime, MobiMed ePR, - an electronic patient record for decision support, collection of patient data and clinical documentation, MobiMed enRoute, - a tool for navigation and case management, and MobiMed Life - a range of stand-alone defibrillators.

MobiMed saves vital seconds and enable healthcare professionals make the right decisions in critical situations. MobiMed also contributes to improved quality of care and saved resources.

Ortivus Class A and Class B shares are listed on the NASDAQ Stockholm Small Cap list.

Read more about Ortivus at www.ortivus.com

This information is information that Ortivus is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-04-05 08:25 CEST.

Attachments

The Nomination Committee proposes a new Chairman of the Board for Ortivus AB